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predominantly positive. However, experts refer to methodological deficits and only 
few would recommend the use of the instruments in practice. ConClusions: 
There are many questionnaires to assess workability and related concepts. 
However, only few seem to be scientifically sound and valid and at the same time 
applicable for a broad use in practice.
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Does one size Fit All? - ChAllenges FACeD when ADAPting 
tRAnslAtions FoR An eleCtRoniC PlAtFoRM
Oke L, Anderson H, Williams H
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objeCtives: Identify the principal challenges faced during migration from paper 
to electronic platform when placeholders are used within translated content, as 
eCOA questionnaires will often use placeholders which are replaced by other 
words/numbers when the software is running (string concatenation) Methods: 
110 reviews across 22 languages were collated; languages facing issues with place-
holders were identified; problems and resolutions were compared and results 
were reviewed in order to identify patterns. Results: Just over 40% of languages 
had issues with the population of software placeholders. Two main problems 
were found: (1) Issues involving articles and pronouns (including use of multiple 
articles/neutral pronouns/other gender agreements) – For example, Italian uses 
articles (al/alla) before a noun, so when a noun of either gender is electronically 
inserted into a sentence, the simplest resolution was to include all variations of 
the article before every placeholder. However in French where 3 kinds of article 
were required the result was too long, and a gender-neutral pronoun was used. 
(2) Some languages use two or more noun cases which raised issues. For example, 
Czech nouns change form depending on how they’re used in sentences but the 
running software inserted the same form of the noun everywhere. It was decided 
that the auto-populated text would be altered to fit the majority of cases, and 
instances which were an exception would be replaced with static text to ensure 
they appeared correctly. ConClusions: There are frequently issues with string 
concatenation that require in-depth discussion, as very few languages function 
in the same way as English. However, the issues that arose here could be resolved 
with careful consideration between the lead linguist and the project manager. 
All challenges were dealt with on an individual basis to attain a translation that 
reflects the source in the most natural way possible whilst still remaining true 
to the source.
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objeCtives: Patient-Reported Outcome (PRO) instruments are increasingly 
being utilized in drug development to provide a holistic understanding of the 
drugs impact. Such data can be beneficial in clinical decision making. This review 
sought to identify and discuss the PRO instruments used in Phase 3 trials of the 
newer classes of drugs for the treatment of Type 2 diabetes (T2DM). Methods: A 
search was conducted in medline, psychinfo, cinahl, and clinicaltrials.gov using 
17 drug names contained within the following classes: GLP-1 receptor agonists, 
novel insulins, SGLT-2 inhibitors, and DPP-4 inhibitors. This search was supple-
mented with EASD and ADA abstract database searches from 2012-2014. PRO 
instruments used in Phase 3 trials were identified and categorized by measure-
ment concept(s). The items and domains contained within the PRO instruments 
were further explored and summarized. Results: Twenty PRO instruments have 
been used, although none in DPP-4 inhibitor trials. PRO instruments were used 
to measure six separate concepts: treatment satisfaction (10/17 drugs), health-
related quality of life (HRQoL) (8/17), impact of weight/eating-related outcomes 
(6/17), symptoms of diabetes (3/17), psychological well-being (3/17), and cogni-
tive functioning (1/17). Although several PRO instruments were used to measure 
the same concept, the items and domains that comprised that concept differed 
across instruments. For example, only two of the seven treatment satisfaction 
questionnaires contain items pertaining to the injectable therapy device. In addi-
tion, some PRO instruments did not comprehensively evaluate the concept that 
they claimed. For example, an item-level analysis of the EQ-5D, identified as a 
measurement of HRQoL, suggests that it more accurately measures functional 
health status, thereby representing only one dimension of HRQoL. ConClusions: 
PRO data are available for many recently approved drugs in T2DM. More work 
is needed to highlight the relevance and importance of PRO data from pivotal 
trials as an important consideration for physicians when making treatment 
decisions.
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objeCtives: To develop a checklist of essential items, which authors should con-
sider when reporting studies of mapping to preference-based measures from other 
outcome measures. The aim of the checklist (the MApping onto Preference-based 
measures reporting Standards (MAPS) statement) is to promote complete and trans-
parent reporting by researchers. Methods: A working group of health economists 
and a Delphi methodologist was convened. Candidate items for the checklist were 
identified through a structured review of the literature and reviewed by the working 
group. A modified Delphi survey, with representatives from academia, consultancy, 
health technology assessment agencies and the biomedical journal editorial com-
munity, was used to identify a list of essential reporting items from the set of can-
with MTX alone or in combination, to explore their experience. Qualitative analysis 
was performed to develop a conceptual model of the factors influencing adher-
ence to MTX. Based on this model, items were generated using patients’ verbatim, 
and comprehension tested with 18 RA patients. Acceptability and applicability of 
the resulting pilot version were then assessed in clinical practice during consul-
tation, with 10 rheumatologists, using the PRAgmatic Content and face validity 
Test. Results: Several factors associated with poor adherence to MTX were elicited 
from the analysis of the exploratory interviews: barriers (practical, physical, emo-
tional, cognitive, financial), side effects, treatment perceived efficacy; doctor-related 
factors, patients’ beliefs, expectations and behaviors towards treatment, and exter-
nal sources. The resulting MTX Adherence Questionnaire included 29 questions, plus 
three about MTX administration mode and dose, divided into 5 sections: “Practical 
aspects of MTX”; “Me and MTX”; “Efficacy of MTX”; “My feelings about MTX”; “My 
opinion regarding my care”; “MTX treatment in general”. Rheumatologists accepted 
very well the questionnaire and found it useful to enhance communication with 
their patients (n= 8/10). ConClusions: The MTX Adherence Questionnaire is a 
patient self-administered tool that identifies patients facing adherence issues with 
MTX, and thereby helps clinicians make better-informed treatment decisions. It is 
suitable for use in clinical practice. A validation study to assess its robustness in 
research and clinical practice is being set up.
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RheuMAtoiD ARthRitis oR sPonDyloARthRitis, using A novel 
questionnAiRe
Gossec L1, Chauvin P2, Hudry C3, Mathoret-Philibert F3, Poussière M4, de Chalus T5, Russo-
Marie F6, Joubert J7, Saraux A8, Berenbaum F9
1Sorbonne Universités, Université Pierre et Marie Curie, AP-HP, Hôpital Pitié Salpêtrière, Paris, 
France, 2French National Institute of Health and Medical Research (INSERM), Paris, France, 3AP-
HP Hôpital Cochin, Paris, France, 4Independent Researcher, Paris, France, 5UCB Pharma, Colombes, 
France, 6Arthritis Fondation Courtin, Neuilly-sur-Seine, France, 7UCB Pharma, Paris, France, 8CHU 
de la Cavale-Blanche, Brest Cedex, France, 9Sorbonne Universités, Université Pierre et Marie Curie, 
AP-HP, Hôpital Saint-Antoine, Paris, France
objeCtives: Patients with chronic inflammatory disorders, such as rheumatoid 
arthritis (RA) or spondyloarthritis (SpA), have personal sets of fears and beliefs 
related to their disease that may influence the patient-physician relationship and 
treatment adherence. The objective was to describe the most frequent fears and 
beliefs in RA and SpA patients. Methods: Cross-sectional assessment of unse-
lected patients with a diagnosis of RA (ACR/EULAR criteria) or axial SpA (axSpA)
(ASAS criteria) in France in 2014. The study was proposed to all rheumatologists in 
France. A self-reported 44-item questionnaire (25 items on fears, 19 on beliefs) was 
built and preliminarily validated for this study. Each item was scored 0–10 (10 indi-
cating higher fears/stronger beliefs). The analysis was descriptive for the 5 fears and 
5 beliefs most frequently scored as ≥ 7/10, in both axSpA and RA patients. Results: 
Overall, 226 patients (161 RA, 65 axSpA; 64.4% female) were analyzed: mean dis-
ease duration 11.9 vs 13.8 years and mean patient’s global assessment 31/100 vs 
41/100 for RA vs axSpA patients, respectively. Of the 25 listed fears, the 6 most 
frequently reported were: “afraid of suffering again” (66.7% scored this as ≥ 7/10), 
“afraid of losing control and autonomy” (61.4%), “afraid of being a burden for rela-
tives” (59.6%), “afraid of losing all joint mobility” (58.9%), “afraid of the spread of 
the disease to other joints” (58.6%) and “afraid of the consequences of my disease 
on my professional activity” (58.6%). Of the 19 listed beliefs, the 5 most frequently 
reported were: “flares are triggered by fatigue” (41.7%), “physical activity reduces 
flares” (38.7%), “flares are triggered by changes in the weather” (37.3%), “flares are 
triggered by physical effort” (37.1%) and “the disease is linked to a genetic cause” 
(36.9%). ConClusions: This study highlights the main fears and beliefs from a 
patient perspective using a novel questionnaire specific to chronic inflammatory 
arthritis.
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objeCtives: Currently there is no standardized tool or questionnaire to measure 
workability and related concepts. Instead, there are various different instruments 
researchers and practitioners can choose between. However, a comprehensive 
review is still lacking and there is no evidence which instruments are used in prac-
tice. The objective of this paper is to identify, describe and evaluate the existing 
instruments for measuring workability, presenteeism, productivity and related 
concepts and to assess the status quo regarding the use and awareness of the 
instruments in Germany. Methods: We adopted a 2-step-approach: (1) PubMed, 
the Cochrane Library and ScienceDirect were searched for relevant articles pub-
lished before August 2014. Internet search and scanning reference lists comple-
mented our search. Two authors independently reviewed titles, assessed articles’ 
eligibility and extracted relevant data. Instruments identified in literature were 
briefly described and evaluated. (2) Experts from rehabilitation, health manage-
ment/economics and representatives of the medical profession were interviewed 
on their experiences with measuring workability. The survey was based on a 
semi-standardized, structured guideline and conducted by telephone. Results: 
(1) Systematic review revealed 4665 articles. Thereof 357 were included in further 
research. In total, we identified 57 instruments (including different versions of 
single instruments). Instruments vary significantly regarding content, response 
format, length, etc. Instruments most often used include WPAI, WLQ, SPS, HPQ, 
HLQ, WAI and MIDAS. (2) Results of the interviews indicate that the WAI and WPAI 
are the instruments most common and also most often used in Germany. Both 
tools are considered appropriate for measuring workability and experiences are 
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health-states valuations. Methods: A battery of standard measures of happiness 
was applied to 110 economics students at Universidad Nacional de Colombia: global 
happiness, affect equilibrium, life satisfaction, Gallup’s happiness ladder, Diener’s 
life satisfaction, Liubomirsky’s subjective happiness scale, and satisfaction in par-
ticular areas. Participants performed a Visual Analog Scale valuation of five EQ-5D 
health states: one severe, two mild and two medium. Health states were described 
generically. Only better-than-death valuations were taken into account. Individuals 
valuing a state as worse than death were excluded from that state. Results: The 
total number of valid observations for each heath state fell between 100 and 110, with 
the exception of the severe state (62). Results were different depending on health-
state and test. Gallup’s ladder and life satisfaction tests were not correlated with any 
valuation. A medium health state was not correlated to any happiness test. Severe 
states were more correlated to emotions than milder states. “Not very happy” people 
in the Global happiness test had lower valuations for a mild state (rho= -0.224, p< 0.10). 
Positive affects were negatively correlated with valuations. (rho= -0.306, -.0252, p< 0.05, 
p< 0.10, rho= 0.335, p< 0.05, rho= -282, p< 0.05). Negative affects increased valuations of 
a medium and a mild states (rho= 0.25, 0.313, p< 0.10). Satisfaction in particular areas 
of life also had an impact on extreme states. ConClusions: Some states, but not 
all, seem to be more easily affected by emotional variables. The results suggest that 
more severe health states are valued higher when the respondent has had negative 
affects, and lower when she has had positive affects.
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quAlitAtive equivAlenCe between PAPeR AnD eDiARy veRsions AnD 
usAbility oF 6 PRo questionnAiRes FoR enDoMetRiosis
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objeCtives: This study evaluated the qualitative equivalence between paper and 
electronic diary (eDiary) versions of the following 6 patient-reported outcome (PRO) 
instruments used in endometriosis studies: Dysmenorrhea (DYS), Non-menstrual 
Pelvic Pain (NMPP), Dyspareunia, Uterine Bleeding, Numeric Rating Scale (NRS), and 
Menstrual Period. Study medication and Analgesic Medication questions were also 
assessed for usability. Equivalence evaluation of these questionnaires in an eDiary 
was needed to document suitability of this mode of data collection for upcom-
ing clinical trials. Methods: A cross-sectional qualitative study was conducted 
involving cognitive and usability interviews with premenopausal women diagnosed 
with endometriosis recruited from 2 US sites. The 6 symptom questionnaires and 
2 medication questionnaires were administered on an HTC HD2 eDiary and paper 
versions. Participants were randomized to order of mode completion to control 
for order effects. Interviews were conducted in two rounds to allow for evalua-
tion of issues between rounds. Results: Mean age of the sample (N= 10) was 31 
years, (range 25-46), 70% were white; 50% were employed part-time; 50% had com-
pleted secondary school or some college, while 50% had completed a college degree. 
Participants found the training useful, device easy to use, considered the platforms 
and formats to be similar, and preferred the eDiary to paper. No usability issues were 
noted in the PRO or medication questions, although one participant suggested a 
larger device would be easier for some participants to read. Only one instance of a 
discrepancy in response between the formats occurred, and was due to perceived 
similarity between the adjacent responses Mild and Moderate, not due to the device. 
No changes were made between rounds. ConClusions: The study showed excel-
lent qualitative equivalence between paper and electronic versions of 6 PRO ques-
tionnaires. This study also supported usability of the eDiary with an endometriosis 
population which expressed a strong preference for the electronic version.
PRM193
MAPPing oF the 16-iteM soRt FoRM veRsion oF the MenoPAuse 
CeRvAntes heAlth-RelAteD-quAlity-oF-liFe sCAle onto the eq-5D-3l
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objeCtives: The Cervantes scale is a specific health-related-quality-of-life (HRQoL) 
questionnaire developed in Spanish women through and beyond menopause. The 
16-item form (Cervantes-SF) is structured in 6 dimensions: Vasomotor Symptoms, 
Health, Psychological Health, Aging, Sexuality, and Couple Relations. The aim of 
this work was to obtain a scoring algorithm for mapping the specific Cervantes-SF 
scores onto the generic EuroQoL-5D-3L (EQ-5D) for peri-menopausal and postmeno-
pausal women. Methods: We designed a cross-sectional study enrolling peri and 
ostmenopausal adult women attending outpatient clinics of Gynecology all over the 
country in Spain. All of the patients completed both scales, the Cervantes-SF and 
the EQ-5D-3L. Several mapping methods were tested to predict EQ-5D utility values: 
Picewise regression based on item decomposition into dummy indicators, Picewise 
regression with profile aggregated data and Probit regression. R2, Mean Absolute 
Error, Mean Average Percentual Error (MAPE), along with coefficient significance 
were used to compare models. Age, body mass index (BMI) and being sexually active 
were also variables tested within models. Results: A sample of 275 women [mean 
age 55 years old (SD= 5.37)] was enrolled, with mean BMI= 25.2 (SD= 4.3) and 83% 
being sexually active. Most important dimensions were Aging, Health, Psychological 
health, and the interaction term for severity and BMI. Picewise regression with 
profile aggregated data performed best although differences between models were 
small. Goodness-of-fit statistics were good or very good: R2= 0.52, MAE= 0.019, 
MPE= -0.1%, MAPE= 12% and RMSE= 0.126. ConClusions: An algorithm for mapping 
menopause specific health states measured by the abridged 16-item Cervantes scale 
(Cervantes-SF) onto general HRQoL utilities has been obtained, allowing computing 
QALYs related to menopause impairment.
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didate items. The survey was administered via the web in two rounds. Results: 
29 reporting items were identified from the literature and reduced to 25 following 
review by the Working Group. A total of 48 individuals agreed to participate in the 
Delphi panel, of whom 46 (96%) and 39 (85%) responded to the first and second 
rounds, respectively. The 25 items were reduced to 23 following the first round of 
the survey, and all 23 items were rated as important with no evidence of disagree-
ment on ratings of any items in the second round. For each item, we summarise the 
recommendation, provide a detailed explanation and illustrate it using an exemplar 
of good reporting practice identified from the published literature. ConClusions: 
There was good agreement for the final set of items included in the checklist. It is 
anticipated that the MAPS statement will promote clarity, transparency and com-
pleteness of reporting of mapping studies. It is targeted at researchers developing 
mapping algorithms, peer reviewers and editors involved in the manuscript review 
process for mapping studies, and the funders of the research.
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tRAnslAtion AnD linguistiC vAliDAtion oF the CARegiveR quAlity oF 
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objeCtives: Cystic fibrosis (CF) imposes a considerable humanistic and socio-
economic burden on caregivers. CQOLCF scale is a 35-item, disease-specific self-
report instrument used to evaluate physical/emotional/family/social functioning 
of caregiver of a child with CF. MSPSS is a 12-item, generic instrument used to 
evaluate perceptions of social support. This study aimed to translate and linguisti-
cally validate the CQOLCF and the MSPSS into German for Germany, and to review 
and linguistically validate the same measures into English for the UK. Methods: 
The original US-English versions of the CQOLCF and MSPSS were translated into 
German and UK-English complying with ISPOR’s Principles of Good Practice for 
translation and linguistic validation of PRO measures. Methodology for the German 
versions of the CQOLCF and the MSPSS included: concept elaboration, forward 
translation by two native German speakers, reconciliation, two independent back 
translations, back translation review, review by original instrument developer, 
independent proofreading, pilot testing with five caregivers of children with CF in 
Germany, pilot testing review, investigator proofreading, and final quality assurance 
checks. Methodology for the UK-English versions included: concept elaboration, in-
country review, review by original instrument developer, independent proofreading, 
pilot testing with five caregivers of children with CF in the UK, pilot testing review, 
investigator proofreading, and final quality assurance checks. Results: Following 
pilot testing, minor changes were made to two items in the German (instructions: 
referring to ‘carer’; item 15: referring to ‘mental strain’) and UK-English versions 
(item 5: referring to ‘personal interests’; item 13: referring to ‘limiting my focus’) 
of the CQOLCF and one item (addition of the word ‘please’ to instructions) in the 
MSPSS UK-English version. ConClusions: The German and UK-English versions 
of the CQOLCF and the MSPSS were found appropriate for use among caregivers of 
pediatric patients with CF and were certified as true and accurate translations of 
the original source documents.
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objeCtives: Many intervention based studies aiming to improve mental health 
do not include a multi-attribute utility instrument (MAUI) that produces quality-
adjusted life-years (QALYs). It limits the applicability of health economic analyses 
and means that the validity of comparability of cost-effectiveness between dif-
ferent interventions is diminished. The aim of this study is to assess the relation-
ship between commonly used measures for psychological distress General Health 
Questionnaire (GHQ-12) and MAUI EuroQoL (EQ-5D), and develop ‘crosswalk’ trans-
formation algorithms between the measures. Methods: The study is based on a 
postal survey questionnaire sent to a random sample of men and women in four 
counties in central part of Sweden, from 16 -84 years old in 2012. The study popula-
tion included 32,500 respondents. EQ-5D index was calculated using Swedish tariffs 
values. The survey included both GHQ12 and EQ-5D instruments, as well as questing 
about self-rated health. An OLS model was used to estimate EQ-5D health states 
values using GHQ-12 as exposure, using the respondents of two counties (n= 17,000). 
The algorithm was applied to the respondents from another two counties, 
(n= 15,500) to check the predictive capacity of the model. Results: EQ-5D index 
scores decreased as the GHQ-12 scores increased. The final model included 
sex, age, self-rated health in 5 ordinal levels and GHQ-12 scores as a quantita-
tive variable. The regression equation explained 40% of the variance. For estima-
tion of utility scores, the model showed a satisfying predictive capacity between 
observed and predicted EQ-5D index score with Pearson correlation = 0.65, MAE 
(mean absolute error)= 0.12 and mean relative absolute error (MAE/mean(observed 
EQ-5D))= 14.6%. ConClusions: The algorithms developed in this study can be used 
to determine cost-effectiveness of services or interventions that use GHQ12 as a 
primary outcome where utility measures are not collected.
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objeCtives: Emotions have an effect on economic choices and financial valua-
tions. The aim of this study is to determine whether happiness has an effect on 
